NASDAQ · BGMS

Bio Green Med Solution, Inc.

$0.92 +$0.01 (+1.08%) 1D After hours

Key Metrics

$5.05M
Market cap
P/E · TTM
$743.00K
Revenue · TTM
−$3.11M
Net income
EPS · TTM $-0.57
Dividend yield
Free cash flow
Beta · 1Y 2.02
EBITDA · TTM −$3.07M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    From its Jun 5 high, the share price fell 60%.

    Peak close $1.50 on Jun 5; trough close $0.60 on Jun 26. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -60%
  • Jun 5
    The stock moved +41.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 5
  • Feb 6
    The stock moved +33.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.05M
Enterprise value
Shares outstanding5.5M
52-wk range$0.57 – $6.70
Avg volume · 20D855.6K
Net cash
Book value / share$1.24
IndustryPharmaceutical Preparations
ExchangeNASDAQ
About Bio Green Med Solution, Inc.
IPO dateMar 28, 2006
Employees19

Bio Green Med Solution Inc is engaged in the supply and trading of protective and fire safety equipment. The company distributes products such as fire extinguishers, foam systems, fire-resistant doors, personal protective equipment, and safety apparel.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S6.80
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating -414.1%
Net -419.1%
FCF
ROE / ROIC -135.8% · -130.6%

Financial Health

Current ratio7.06
Quick ratio5.87
Debt / equity
Debt / EBITDA
Net cash
Working capital$4.83M

Cash Flow · TTM

Operating CF −$1.80M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-80.9
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings